Search results for HLA A antibody

APC Anti-HLA-DP antibody [SP228], Abcam, AB306518

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

APC Anti-HLA-DQA1 antibody [EPR7300], Abcam, AB319261

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

FITC Anti-HLA A2 antibody [BB7.2], Abcam, AB27728

FITC Anti-HLA B7 antibody [BB7.1], Abcam, AB33330

This antibody can be used to distinguish true HLA B27 positives from false HLA B27 positives (i.e. HLA B7 positive) in the investigation of diseases such as ankylosing spondylitis and anterior uveitis.

FITC Anti-HLA-DR antibody [GRB1], Abcam, AB91335

FITC Anti-HLA-DR antibody [L243], Abcam, AB210298

FITC Anti-HLA-DR antibody [LN3], Abcam, AB1182

Leukocyte Antigen G (HLA-G) Antibody, Abbexa, abx139512

HLA-G Antibody is a Mouse Monoclonal against HLA-G.

Leukocyte Antigen G (HLA-G) Antibody, Abbexa, abx034900

Involved in the presentation of foreign antigens to the immune system. Plays a role in maternal tolerance of the fetus by mediating protection from the deleterious effects of natural killer cells, cytotoxic T-lymphocytes, macrophages and mononuclear cells.

HLA class I (HLA-B) Antibody, Abbexa, abx233897

HLA class I (HLA-B) Antibody is a Rabbit Polyclonal against HLA class I (HLA-B).